XTSX
PCLO
, Last price
CAD
Name
Pharmacielo Ltd
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
10.81%
Rev. 5Y
-0.33%
Div Yld LY
—
Div Yld TTM
—
Revenues
3m
-24.97%
Net income
-5m
L-50.19%
CFO
-1m
L-48.25%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PharmaCielo Ltd., operating alongside its subsidiary, specializes in the cultivation, processing, production, and distribution of medical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated products. In addition, the company provides telemedicine software solutions. Its diverse clientele comprises health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies across Canada and Colombia. PharmaCielo Ltd. maintains a strategic alliance with AssuredTrans Inc., and its corporate headquarters are located in Toronto, Canada.
Key people
Chief Executive Officer, Chief Financial Officer, Executive Director · since 2017
Global Head, Health and Innovation
David Attard
Chief Executive Officer, Director
Director
Chairman of the Board
Matteo Lorenzo Pellegrini
Director
Henning Von Koss
Director
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑08 | 2017‑08 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||